Delivery Order SPE2DB24D2101-SPE2DB25FKNTT
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count) with a ceiling value of $4,048.75. This delivery order represents a firm fixed price contract with no set-aside designation, indicating it was awarded through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count packages) with a ceiling value of $9,373.09. This is a firm fixed-price delivery order with no set-aside designation, completed competitively through open procurement. The order is scheduled for completion by August 21, 2025, with performance to take place at AmerisourceBergen's corporate headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,586.69 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 40 mg capsules (30-count units) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price, non-set-aside contract was performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 10 mg capsules (30-count) with a ceiling value of $1,075.65. This competitive award, issued on July 21, 2025, represents a firm fixed-price delivery order with a completion date of July 22, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,056.22 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 20 mg capsules (30-count) on August 19, 2025, with completion targeted for August 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count) with a ceiling value of $1,011.63. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order is set for ultimate completion on July 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count) under a firm fixed-price contract valued at $3,433.16. The delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, does not utilize a set-aside designation and was competitively awarded. Performance will be completed by the ultimate completion...
- The Defense Logistics Agency awarded a delivery order valued at $4,960.54 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 40 mg capsules (30-count) on August 13, 2025, with completion scheduled for August 14, 2025. The contract employs firm fixed pricing and is not set-aside designated, indicating it was competitively awarded. Performance will take place at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,370.84 to AmerisourceBergen Drug Corp for Carvedilol ER 80 mg capsules (30-count) on August 15, 2025, with completion scheduled for August 18, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,976.45 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 40 mg capsules (30-count units) on July 24, 2025, with completion targeted for July 25, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The place...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKNTTDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $34,205.26 to AmerisourceBergen Drug Corp for Carvedilol ER 20 mg capsules (30-count units) on August 22, 2025, with an ultimate completion date of August 25, 2025. The contract represents a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to deliver a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, generic drugs, and medical devices across multiple therapeutic domains. This specific delivery order for Carvedilol, a cardiovascular medication, reflects the company's ongoing role in supplying essential pharmaceutical commodities to support Defense Health Agency requirements and other government healthcare systems through DLA's Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.2k | 8/22/25 |